Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Helen & Robert Appel Alzheimer’s Disease Research Institute
Explore this Website
Home
About Us
Toggle About Us menu options
About Alzheimer's
Open Positions
Staff Directory
Faculty
Toggle Faculty menu options
Gan Laboratory
Orr Laboratory
Burré Laboratory
Sharma Laboratory
Sinha Laboratory
Wu Laboratory
Postdoc Initiative
Toggle Postdoc Initiative menu options
API Events
News & Events
Toggle News & Events menu options
Events
News
Giving
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Faculty
Postdoc Initiative
News & Events
Giving
Contact Us
Home
Publications
Publications
Found 362 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
G
[Clear All Filters]
2003
Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC et al.
. 2003.
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho.
.
Science. 302(5648):1215-7.
Benharouga M, Sharma M, So J, Haardt M, Drzymala L, Popov M, Schwapach B, Grinstein S, Du K, Lukacs GL
. 2003.
The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia.
.
J Biol Chem. 278(24):22079-89.
2002
Gong S, Yang XWilliam, Li C, Heintz N
. 2002.
Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication.
.
Genome Res. 12(12):1992-8.
Dodart J-C, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM et al.
. 2002.
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
.
Nat Neurosci. 5(5):452-7.
Dodart J-C, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM et al.
. 2002.
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
.
Nat Neurosci. 5(5):452-7.
Bhattacharjee A, Gan L, Kaczmarek LK
. 2002.
Localization of the Slack potassium channel in the rat central nervous system.
.
J Comp Neurol. 454(3):241-54.
Gan L, Anton KE, Masterson BA, Vincent VAM, Ye S, Gonzalez-Zulueta M
. 2002.
Specific interference with gene expression and gene function mediated by long dsRNA in neural cells.
.
J Neurosci Methods. 121(2):151-7.
Gan L, Anton KE, Masterson BA, Vincent VAM, Ye S, Gonzalez-Zulueta M
. 2002.
Specific interference with gene expression and gene function mediated by long dsRNA in neural cells.
.
J Neurosci Methods. 121(2):151-7.
2001
Reichlin A, Hu Y, Meffre E, Nagaoka H, Gong S, Kraus M, Rajewsky K, Nussenzweig MC
. 2001.
B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta.
.
J Exp Med. 193(1):13-23.
Rho J, Gong S, Kim N, Choi Y
. 2001.
TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo.
.
Mol Cell Biol. 21(24):8365-70.
2000
Kronin V, Wu L, Gong S, Nussenzweig MC, Shortman K
. 2000.
DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses.
.
Int Immunol. 12(5):731-5.
Guo M, Gong S, Maric S, Misulovin Z, Pack M, Mahnke K, Nussenzweig MC, Steinman RM
. 2000.
A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.
.
Hum Immunol. 61(8):729-38.
Guo M, Gong S, Maric S, Misulovin Z, Pack M, Mahnke K, Nussenzweig MC, Steinman RM
. 2000.
A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.
.
Hum Immunol. 61(8):729-38.
1999
Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V et al.
. 1999.
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
.
Proc Natl Acad Sci U S A. 96(26):15233-8.
Gan L, Hahn SJ, Kaczmarek LK
. 1999.
Cell type-specific expression of the Kv3.1 gene is mediated by a negative element in the 5' untranslated region of the Kv3.1 promoter.
.
J Neurochem. 73(4):1350-62.
Xu X, Yang D, Wyss-Coray T, Yan J, Gan L, Sun Y, Mucke L
. 1999.
Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis.
.
Proc Natl Acad Sci U S A. 96(13):7547-52.
1998
Wang LY, Gan L, Perney TM, Schwartz I, Kaczmarek LK
. 1998.
Activation of Kv3.1 channels in neuronal spine-like structures may induce local potassium ion depletion.
.
Proc Natl Acad Sci U S A. 95(4):1882-7.
Wang LY, Gan L, Forsythe ID, Kaczmarek LK
. 1998.
Contribution of the Kv3.1 potassium channel to high-frequency firing in mouse auditory neurones.
.
J Physiol. 509 ( Pt 1):183-94.
Joiner WJ, Tang MD, Wang LY, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, Kaczmarek LK
. 1998.
Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.
.
Nat Neurosci. 1(6):462-9.
Joiner WJ, Tang MD, Wang LY, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, Kaczmarek LK
. 1998.
Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.
.
Nat Neurosci. 1(6):462-9.
Ginns EI, St Jean P, Philibert RA, Galdzicka M, Damschroder-Williams P, Thiel B, Long RT, Ingraham LJ, Dalwaldi H, Murray MA et al.
. 1998.
A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish.
.
Proc Natl Acad Sci U S A. 95(26):15531-6.
Ginns EI, St Jean P, Philibert RA, Galdzicka M, Damschroder-Williams P, Thiel B, Long RT, Ingraham LJ, Dalwaldi H, Murray MA et al.
. 1998.
A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish.
.
Proc Natl Acad Sci U S A. 95(26):15531-6.
Gan L, Kaczmarek LK
. 1998.
When, where, and how much? Expression of the Kv3.1 potassium channel in high-frequency firing neurons.
J Neurobiol. 37(1):69-79.
1997
Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP et al.
. 1997.
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.
.
Arch Neurol. 54(4):465-73.
Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ et al.
. 1997.
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
.
Nat Genet. 17(3):263-4.
« first
‹ previous
…
7
8
9
10
11
12
13
14
(current)
15
next ›
last »